Drug Pipeline

Retatrutide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
13
Active Studies
4
Recruiting
10
Phase 3
2
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT07357415
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have…
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-04 NCT05929066
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Trial completed
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-05 NCT07629401 Provide Pre-approval Expanded Access of LY3437943 Available
Active Studies by Phase
Phase 3
10
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07035093 A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and… Obesity Recruiting
NCT07165028 A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated… Metabolic Dysfunction-Associated Steatotic Liver Disease Recruiting
NCT06859268 A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals… Obesity Active, Not Recruiting
NCT05929079 A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have… Type 2 Diabetes Active, Not Recruiting
NCT06260722 Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2… Diabetes Mellitus, Type 2 Active, Not Recruiting
NCT06662383 A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have… Obesity Active, Not Recruiting
NCT07232719 A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight Obesity Active, Not Recruiting
NCT06383390 The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in… Atherosclerotic Cardiovascular Disease (ASCVD) Active, Not Recruiting
NCT05882045 A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease Obesity Active, Not Recruiting
NCT07357415 A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have… Obesity Active, Not Recruiting
Phase 2
NCT07467447 Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight Obesity Recruiting
Phase 1
NCT06982859 A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin… Diabetes Mellitus Recruiting
NCT06982846 A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on… Type 2 Diabetes Mellitus Active, Not Recruiting
Sponsors Running Retatrutide Trials
Disease Areas
Get alerts when Retatrutide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free